Fajadet Jean, Haude Michael, Joner Michael, Koolen Jacques, Lee Michael, Tölg Ralph, Waksman Ron
Department of Interventional Cardiology, Clinique Pasteur, Toulouse, France.
EuroIntervention. 2016 Sep 18;12(7):828-33. doi: 10.4244/EIJV12I7A137.
Bioresorbable scaffolds represent an exciting milestone in the development of coronary stent technology with the potential to substantially improve the management of patients with coronary artery disease. In an attempt to provide first recommendations for the technology, experienced experts involved in the first-in-man studies met in Zurich on the 14 April 2016 in order to reach consensus on a responsible market introduction. This document will be updated regularly as new information from clinical trials becomes available and should be understood as a review of current data, opportunities, expectations, advice, and recommendations for future investigations.
生物可吸收支架代表了冠状动脉支架技术发展中一个令人振奋的里程碑，具有显著改善冠状动脉疾病患者治疗效果的潜力。为了为该技术提供首批建议，参与人体首次研究的经验丰富的专家于2016年4月14日在苏黎世会面，以便就负责任的市场推广达成共识。随着临床试验的新信息不断出现，本文件将定期更新，应将其理解为对当前数据、机会、期望、建议以及未来研究推荐的综述。
